Referencias►
1.
Alaimo K, McDowell MA, Briefel RR, et al. Dietary intake of vitamins, minerals and fiber of persons age 2 months and over in the United States: Third National Health and Nutrition Examination Survey, phase 1, 1988 - 91.
Advance Data from Vital and Health Statistics.
1994;258:1-26.
2.
Wester PO. Magnesium.
Am J Clin Nutr. 1987;45(suppl):1305 - 1312.
3.
Spencer H, Norris C, Williams D. Inhibitory effects of zinc on magnesium balance and magnesium absorption in man.
J Am Coll Nutr. 1994;13:479 - 484.
4.
Martin BJ, Milligan K. Diuretic-associated hypomagnesemia in the elderly.
Arch Intern Med.
1987;147:1768 - 1771.
5.
Seelig MS. Interrelationship of magnesium and estrogen in cardiovascular and bone disorders, eclampsia, migraine and premenstrual syndrome.
J Am Coll Nutr.
1993;12:442 - 458.
6.
Spatling L, Spatling G. Magnesium supplementation in pregnancy. A double-blind study.
Br J Obstet Gynaecol. 1988;95:120 - 125.
7.
Sibai BM. Prevention of preeclampsia: a big dissapointment.
Am J Obstet Gynecol. 1998;179:1275 - 1278.
8.
Lewis NM, Marcus MS, Behling AR, et al. Calcium supplements and milk: effects on acid-base balance and on retention of calcium, magnesium, and phosphorus.
Am J Clin Nutr.
1989;49:527 - 533.
9.
Andon MB, Ilich JZ, Tzagournis MA, et al. Magnesium balance in adolescent females consuming a low- or high-calcium diet.
Am J Clin Nutr.
1996;63:950 - 953.
10.
Peikert A, Wilimzig C, Kohne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study.
Cephalalgia. 1996;16:257 - 263.
11.
Taubert K. Magnesium in migraine. Results of a multicenter pilot study [in German; English abstract].
Fortschr Med. 1994;112:328 - 330.
12.
Facchinetti F, Sances G, Borella P, et al. Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium.
Headache. 1991;31:298 - 301.
13.
Attias J, Weisz G, Almog S, et al. Oral magnesium intake reduces permanent hearing loss induced by noise exposure.
Am J Otolaryngol.
1994;15:26 - 32.
14.
Johansson G, Backman U, Danielson BG, et al. Biochemical and clinical effects of the prophylactic treatment of renal calcium stones with magnesium hydroxide.
J Urol. 1980;124:770 - 774.
15.
Shechter M, Sharir M, Labrador MJ, et al. Oral magnesium therapy improves endothelial function in patients with coronary artery disease.
Circulation. 2000;102:2353 - 2358.
16.
Sanjuliani AF, de Abreu Fagundes VG, Francischetti EA. Effects of magnesium on blood pressure and intracellular ion levels of Brazilian hypertensive patients.
Int J Cardiol. 1996;56:177 - 183.
17.
Witteman JC, Grobbee DE, Derkx FH, et al. Reduction of blood pressure with oral magnesium supplementation in women with mild to moderate hypertension.
Am J Clin Nutr. 1994;60:129 - 135.
18.
Dyckner T, Wester PO. Effect of magnesium on blood pressure.
Br Med J (Clin Res Ed). 1983;286:1847 - 1849.
19.
Shechter M, Merz CN, Paul-Labrador M, et al. Beneficial antithrombotic effects of the association of pharmacological oral magnesium therapy with aspirin in coronary heart disease patients.
Magnes Res. 2000;13:275 - 284.
20.
Kummerow FA, Zhou Q, Mafouz MM. Effects of trans fatty acids on calcium influx into arterial endothelial cells.
Am J Clin Nutr.
1999;70:832 - 838.
21.
Fontana-Klaiber H, Hogg B. Therapeutic effects of magnesium in dysmenorrhea [in German; English abstract].
Schweiz Rundsch Med Prax. 1990;79:491 - 494.
22.
Seifert VB, Wagler P, Dartsch S, et al. Magnesium - a new therapeutic alternative in primary dysmenorrhea [translated from German].
Zentralbl Gynakol. 1989;111:755 - 760.
23.
Facchinetti F, Borella P, Sances G, et al. Oral magnesium successfully relieves premenstrual mood changes.
Obstet Gynecol. 1991;78:177 - 181.
24.
Facchinetti F, Sances G, Borella P, et al. Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium.
Headache. 1991;31:298 - 301.
25.
Hornyak M, Voderholzer U, Hohagen F, et al. Magnesium therapy for periodic leg movements - related insomnia and restless legs syndrome: An open pilot study.
Sleep.
1998;21:501 - 505.
26.
Popoviciu L, Asgian B, Delast-Popoviciu D, et al. Clinical, EEG, electromyographic and polysomnographic studies in restless legs syndrome caused by magnesium deficiency.
Rom J Neurol Psychiatry.
1993;31:55 - 61.
27.
Elamin A, Tuvemo T. Magnesium and insulin-dependent diabetes mellitus.
Diabetes Res Clin Pract. 1990;10:203 - 209.
28.
Tosiello L. Hypomagnesemia and diabetes mellitus: A review of clinical implications.
Arch Intern Med. 1996;156:1143 - 1148.
29.
Eibl NL, Kopp HP, Nowak HR, et al. Hypomagnesemia in type II diabetes: Effect of a 3-month replacement therapy.
Diabetes Care. 1995;18:188 - 192.
30.
Martineau J, Barthelemy C, Garreau B, et al. Vitamin B6, magnesium, and combined B6-Mg: therapeutic effects in childhood autism.
Biol Psychiatry.
1985;20:467 - 478.
31.
Pfeiffer SI, Norton J, Nelson L, et al. Efficacy of vitamin B6 and magnesium in the treatment of autism: a methodology review and summary of outcomes.
J Autism Dev Disord.
1995;25:481 - 493.
32.
Barthelemy C, Garreau B, Leddet I, et al. Behavioral and biological effects of oral magnesium, vitamin B6 and combined magnesium - vitamin B6 administration in autistic children.
Magnes Bull.
1981;2:150 - 153.
33.
Lelord G, Callaway E, Muh JP. Clinical and biological effects of high doses of vitamin B6 and magnesium on autistic children.
Acta Vitaminol Enzymol.
1982;4:27 - 44.
34.
Lelord G, Muh JP, Barthelemy C. Effects of pyridoxine and magnesium on autistic symptoms - initial observations.
J Autism Dev Disord.
1981;11:219 - 230.
35.
Martineau J, Garreau B, Barthelemy C, et al. Effects of vitamin B6 on averaged evoked potentials in infantile autism.
Biol Psychiatry.
1981;16:627 - 641.
36.
Rimland B, Callaway E, Dreyfus P. The effect of high doses of vitamin B6 on autistic children: a double-blind crossover study.
Am J Psychiatry.
1978;135:472 - 475.
37.
Cook R, Botting D. Use of orthomolecular therapy for those with behavioural problems and mental handicap: a review.
Complement Ther Med.
1997;5:228 - 232.
38.
Rimland B. Controversies in the treatment of autistic children: vitamin and drug therapy.
J Child Neurol.
1988;(suppl 3):S68 - S72.
39.
Rimland B. Vitamin B6 versus fenfluramine: a case-study in medical bias.
J Nutr Med.
1991;2:321 - 322.
40.
Werbach MR. Autism.
Int J Alt Complement Med. 1996;8.
41.
Dahle LO, Berg G, Hammar M, et al. The effect of oral magnesium substitution on pregnancy-induced leg cramps.
Am J Obstet Gynecol. 1995;173:175 - 180.
42.
Bernstein WK, Khastgir T, Khastgir A, et al. Lack of effectiveness of magnesium in chronic stable asthma. A prospective, randomized, double-blind, placebo-controlled, crossover trial in normal subjects and in patients with chronic stable asthma.
Arch Intern Med. 1995;155:271 - 276.
43.
Frick M, Darpo B, Ostergren J, et al. The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation.
Eur Heart J. 2000;21:1177 - 1185.
44.
Finstad EW, Newhouse IJ, Lukaski HC, et al. The effects of magnesium supplementation on exercise performance.
Med Sci Sports Exerc. 2001;33:493 - 498.
45.
Brilla LR, Haley TF. Effect of magnesium supplementation on strength training in humans.
J Am Coll Nutr. 1992;11:326 - 329.
46.
Weller E, Bachert P, Meinck HM, et al. Lack of effect of oral Mg-supplementation on Mg in serum, blood cells, and calf muscle.
Med Sci Sports Exerc. 1998;30:1584 - 1591.
47.
Ruddel H, Werner C, Ising H. Impact of magnesium supplementation on performance data in young swimmers.
Magnes Res. 1990;3:103 - 107.
48.
Ripari P, Pieralisi G, Giamberardino MA, et al. Effects of magnesium pidolate on some cardiorespiratory submaximal effort parameters [abstract].
Magnes Res. 1989;2:70.
49.
Brilla LR, Gunter KB. Effect of magnesium supplementation on exercise time to exhaustion.
Med Exerc Nutr Health. 1995;4:230 - 233.
50.
Terblanche S, Noakes TD, Dennis SC, et al. Failure of magnesium supplementation to influence marathon running performance or recovery in magnesium-replete subjects.
Int J Sport Nutr. 1992;2:154 - 164.
51. Dragani L, Giamberardino MA, Vecchiet L. Effects of magnesium administration on muscle damage from physical exercise. In: Vecchiet L, ed. Magnesium and Physical Activity. New York, NY: Parthenon Publishing Group; 1994:253 - 260.
52.
Sibai BM, Villar MA, Bray E. Magnesium supplementation during pregnancy: A double-blind randomized controlled clinical trial.
Am J Obstet Gynecol.
1989;161:115 - 119.
53.
Kovacs L, Molnar BG, Huhn E, et al. Magnesium substitution in pregnancy. A prospective, randomized double-blind study [translated from German].
Geburtshilfe Frauenheilkd.
1988;48:595 - 600.
54.
Peikert A, Wilimzig C, Kohne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study.
Cephalalgia. 1996;16:257 - 263.
55.
Taubert K. Magnesium in migraine. Results of a multicenter pilot study [in German; English abstract].
Fortschr Med. 1994;112:328 - 330.
56.
Facchinetti F, Sances G, Borella P, et al. Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium.
Headache. 1991;31:298 - 301.
57.
Pfaffenrath V, Wessely P, Meyer C, et al. Magnesium in the prophylaxis of migraine - a double-blind, placebo-controlled study.
Cephalalgia. 1996;16:436 - 440.
58.
Gaby AR. Research Review.
Nutr Healing.
March 1997.
59.
Attias J, Weisz G, Almog S, et al. Oral magnesium intake reduces permanent hearing loss induced by noise exposure.
Am J Otolaryngol.
1994;15:26 - 32.
60.
Li MK, Blacklock NJ, Garside J. Effects of magnesium on calcium oxalate crystallization.
J Urol.
1985;133:123 - 125.
61.
Parivar F, Low RK, Stoller ML. The influence of diet on urinary stone disease.
JUrol.
1996;155:432 - 440.
62.
Johansson G, Backman U, Danielson BG, et al. Biochemical and clinical effects of the prophylactic treatment of renal calcium stones with magnesium hydroxide.
J Urol. 1980;124:770 - 774.
63.
Ettinger B, Citron JT, Livermore B, et al. Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not.
J Urol.
1988;139:679 - 684.
64.
Sanjuliani AF, de Abreu Fagundes VG, Francischetti EA. Effects of magnesium on blood pressure and intracellular ion levels of Brazilian hypertensive patients.
Int J Cardiol. 1996;56:177 - 183.
65.
Witteman JC, Grobbee DE, Derkx FH, et al. Reduction of blood pressure with oral magnesium supplementation in women with mild to moderate hypertension.
Am J Clin Nutr. 1994;60:129 - 135.
66.
Dyckner T, Wester PO. Effect of magnesium on blood pressure.
Br Med J (Clin Res Ed). 1983;286:1847 - 1849.
67.
Henderson DG, Schierup J, Schodt T. Effect of magnesium supplementation on blood pressure and electrolyte concentrations in hypertensive patients receiving long term diuretic treatment.
Br Med J (Clin Res Ed). 1986;293:664-665.
68.
Shechter M, Sharir M, Labrador MJ, et al. Oral magnesium therapy improves endothelial function in patients with coronary artery disease.
Circulation. 2000;102:2353 - 2358.
69.
Livingston JC, Livingston LW, Ramsey R, et al. Magnesium sulfate in women with mild preeclampsia: a randomized controlled trial.
Obstet Gynecol. 2003;101:217 - 220.
70.
Seifert VB, Wagler P, Dartsch S, et al. Magnesium - a new therapeutic alternative in primary dysmenorrhea [translated from German].
Zentralbl Gynakol. 1989;111:755 - 760.
71.
Fontana-Klaiber H, Hogg B. Therapeutic effects of magnesium in dysmenorrhea [in German; English abstract].
Schweiz Rundsch Med Prax. 1990;79:491 - 494.
72.
Facchinetti F, Borella P, Sances G, et al. Oral magnesium successfully relieves premenstrual mood changes.
Obstet Gynecol. 1991;78:177 - 181.
73.
Wyatt KM, Dimmock PW, Jones PW, et al. Efficacy of vitamin B6 in the treatment of premenstrual syndrome: systematic review.
BMJ. 1999;318:1375 - 1381.
74.
Facchinetti F, Sances G, Borella P, et al. Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium.
Headache. 1991;31:298 - 301.
75.
De Souza MC, Walker AF, Robinson PA, et al. A synergistic effect of a daily supplement for 1 month of 200 mg magnesium plus 50 mg vitamin B
6
for the relief of anxiety-related premenstrual symptoms: a randomized, double-blind, crossover study.
J Womens Health Gend Based Med. 2000;
9:131 - 139.
76.
The Magpie Trial Collaborative Group. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial.
Lancet. 2002;359:1877 - 1890.
77.
Rudnicki M, Frolich A, Rasmussen WF, et al. The effect of magnesium on maternal blood pressure in pregnancy-induced hypertension. A randomized double-blind placebo-controlled trial.
Acta Obstet Gynecol Scand. 1991;70:445 - 450.
78.
Galloe AM, Rasmussen HS, Jorgensen LN, et al. Influence of oral magnesium supplementation on cardiac events among survivors of an acute myocardial infarction.
BMJ. 1993;307:585 - 587.
79.
Tolbert L, Haigler T, Waits MM, et al. Brief report: lack of response in an autistic population to a low dose clinical trial of pyridoxine plus magnesium.
J Autism Dev Disord. 1993;23:193 - 199.
80. Nye C, Brice A. Combined vitamin B6-magnesium treatment in autism spectrum disorder (Cochrane Review). Cochrane Database Syst Rev. 2002;CD003497.
81.
Findling RL, Maxwell K, Scotese-Wojtila L, et al. High-dose pyridoxine and magnesium administration in children with autistic disorder: an absence of salutary effects in a double-blind, placebo-controlled study.
J Autism Dev Disord. 1997;27:467 - 478.
82.
Bashir Y, Sneddon JF, Staunton A, et al. Effects of long-term oral magnesium chloride replacement in congestive heart failure secondary to coronary artery disease.
Am J Cardiol. 1993;72:1156 - 1162.
83.
Dahle LO, Berg G, Hammar M, et al. The effect of oral magnesium substitution on pregnancy-induced leg cramps.
Am J Obstet Gynecol. 1995;173:175 - 180.
84.
McGuire JK, Kulkarni MS, Baden HP. Fatal hypermagnesemia in a child treated with megavitamin/megamineral therapy.
Pediatrics.
2000;105:E18.
85.
Tatro D, ed.
Drug Interaction Facts.
St. Louis, Mo: Facts and Comparisons;1999.
86. Drug Evaluations Annual. Vol. 2. Milwaukee, Wis: American Medical Association;1994.
87.
Gaspar AZ, Gasser P, Flammer J. The influence of magnesium on visual field and peripheral vasospasm in glaucoma.
Ophthalmologica. 1995;209:11 - 13.
88.
Elisaf M, Bairaktari E, Kalaitzidis R, Siamopoulos K. Hypomagnesemia in alcoholic patients. Alcohol
Clin Exp Res.
1998;22:244-246.
89.
Kelepouris E and Agus ZS. Hypomagnesemia: Renal magnesium handling.
Semin Nephrol.
1998;18:58-73.
90.
Tosiello L. Hypomagnesemia and diabetes mellitus. A review of clinical implications.
Arch Intern Med.
1996;156:1143-1148.
91.
al-Ghamdi SM, Cameron EC, and Sutton RA. Magnesium deficiency: pathophysiologic and clinical overview.
Am J Kidney Dis. 1994;24:737 - 752.
92.
Institute of Medicine.
Dietary Reference Intakes: Calcium, Phosphorus, Magnesium, Vitamin D and Fluoride.
Washington, DC: National Academy Press; 1999.
93.
Cohen L, Kitzes R. Magnesium sulfate and digitalis-toxic arrhythmias.
JAMA.
1983;249:2808 - 2810.
94.
Toffaletti J. Electrolytes, divalent cations, and blood gases (magnesium).
Anal Chem.
1991;63:192R - 194R.
95.
Whang R, Oei TO, Watanabe A. Frequency of hypomagnesemia in hospitalized patients receiving digitalis.
Arch Intern Med.
1985;145:655 - 656.
96.
Naggar VF, Khalil SA. Effect of magnesium trisilicate on nitrofurantoin absorption.
Clin Pharmacol Ther.
1979;25:857 - 863.
97.
Shechter M, Bairey Merz CN, Stuehlinger HG, et al. Effects of oral magnesium therapy on exercise tolerance, exercise-induced chest pain, and quality of life in patients with coronary artery disease.
Am J Cardiol. 2003;91:517 - 521.
98.
Rodriguez-Moran M, Guerrero-Romero F. Oral Magnesium Supplementation Improves Insulin Sensitivity and Metabolic Control in Type 2 Diabetic Subjects: A randomized double-blind controlled trial.
Diabetes Care. 2003;26:1147 - 1152.
99.
Lichodziejewska B, Klos J, Rezler J, et al. Clinical symptoms of mitral valve prolapse are related to hypomagnesemia and attenuated by magnesium supplementation.
Am J Cardiol. 1997;79:768 - 772.
